Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net (decrease) increase in net assets from operations $ (8,039,620) $ 8,827,612 $ 6,526,650
Adjustments to reconcile net (decrease) increase in net assets to net cash provided by (used in) operating activities:      
Investments in portfolio companies (6,559,755) (13,945,497) (20,347,522)
Proceeds from sale of portfolio investments 990,796 19,421,458 5,889,473
Proceeds from loan repayments 16,831,276 7,903,010 4,111,481
Net realized loss (gain) on portfolio investments 2,001,313 (11,124,864) (1,051,079)
Change in unrealized appreciation/depreciation on investments 11,279,709 6,062,300 (2,972,084)
Deferred tax expense (benefit) 2,161 37,018 (11,019)
Amortization 25,000 25,000 25,000
Original issue discount accretion (41,404) (28,008) (21,008)
Non-cash conversion of debenture interest (2,149,390) (1,980,728) (1,225,773)
Non-cash conversion of loan modification fee (15,000)
Change in interest receivable allowance 25,337
Changes in operating assets and liabilities:      
Decrease (increase) in interest receivable 164,154 (112,930) (36,262)
Decrease in other assets 36,283 48,770 75,801
Decrease (increase) in prepaid income taxes 45,784 (201,496) (51,473)
Increase (decrease) in accounts payable and accrued liabilities 9,407 (52,948) 78,836
(Decrease) increase in due to investment adviser (1,663,559) 1,203,549 417,076
(Decrease) increase in capital gains incentive fees payable (1,565,000) (714,700) 112,700
(Decrease) increase in deferred revenue (125,844) (35,815) 138,285
Total adjustments 19,291,268 6,504,119 (14,867,568)
Net cash provided by (used in) operating activities 11,251,648 15,331,731 (8,340,918)
Cash flows from financing activities:      
Net (repayment of) proceeds from line of credit (600,000) (15,650,000) 13,700,000
Payment of cash dividend (7,277,505) (2,142,247) (3,432,757)
Net cash (used in) provided by financing activities (7,877,505) (17,792,247) 10,267,243
Net increase (decrease) in cash and cash equivalents 3,374,143 (2,460,516) 1,926,325
Cash and cash equivalents:      
Beginning of year 834,805 3,295,321 1,368,996
End of year 4,208,948 834,805 3,295,321
Supplemental disclosure of non-cash financing activities      
Fair value of common stock dividend declared 0 8,672,231 0
Cash dividend declared but not paid $ 0 $ 2,168,058 $ 0